Track the 方盛制药 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 方盛制药 has published 10 reports. Market capitalisation: €4.1bn. The latest transaction was disclosed on 13 May 2025 (Purchase). Among the most active insiders: 何仕. All data is openly available.
10
Insider Decl.
n/a
Thresholds
€588,365
10 ops.
Buy Volume
n/a
n/a
Sell Volume
22Σ signal
Buys €588,365n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 2,568 of 29,064 companies
75.0
score / 100
Value
70
Quality
80
FCF yld6.9%
Earn yld7.5%
EV/EBITDA10.1x
ROE17%
Gross mgn72%
Net mgn18%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.